Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$242.49 - $301.46 $10,669 - $13,264
44 Added 2.23%
2,015 $498,000
Q2 2022

Aug 16, 2022

BUY
$224.73 - $338.64 $138,208 - $208,263
615 Added 45.35%
1,971 $491,000
Q1 2022

May 04, 2022

SELL
$277.25 - $366.29 $148,051 - $195,598
-534 Reduced 28.25%
1,356 $449,000
Q4 2021

Feb 07, 2022

BUY
$300.63 - $371.35 $52,309 - $64,614
174 Added 10.14%
1,890 $679,000
Q3 2021

Nov 10, 2021

BUY
$310.19 - $376.2 $532,286 - $645,559
1,716 New
1,716 $558,000
Q2 2019

Oct 15, 2019

SELL
$250.96 - $284.94 $3.06 Million - $3.47 Million
-12,179 Closed
0 $0
Q1 2019

Oct 15, 2019

BUY
$276.39 - $362.25 $3.37 Million - $4.41 Million
12,179 New
12,179 $968,000

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Formidable Asset Management, LLC Portfolio

Follow Formidable Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Formidable Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Formidable Asset Management, LLC with notifications on news.